
No data
No data
No data
| CAS Number | 29094-61-9 |
| Catalog Number | AG003QRJ(AGN-PC-0R4TDR) |
| Chemical Name | Glipizide |
| EC Number | 249-427-6 |
| IUPAC Name | N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methylpyrazine-2-carboxamide |
| InChI | InChI=1S/C21H27N5O4S/c1-15-13-24-19(14-23-15)20(27)22-12-11-16-7-9-18(10-8-16)31(29,30)26-21(28)25-17-5-3-2-4-6-17/h7-10,13-14,17H,2-6,11-12H2,1H3,(H,22,27)(H2,25,26,28) |
| InChI Key | ZJJXGWJIGJFDTL-UHFFFAOYSA-N |
| MDL Number | MFCD00072159 |
| Molecular Formula | C21H27N5O4S |
| Molecular Weight | 445.5352 |
| NSC Number | 759120 |
| SMILES | C1(CCCCC1)NC(=O)NS(=O)(=O)C1=CC=C(CCNC(=O)C2=NC=C(N=C2)C)C=C1 |
| UNII | X7WDT95N5C |
| Synonyms | Glidiazinamide,
Glipizide,
Glucotrol,
Glupitel,
Glydiazinamide,
Glypidizine,
K 4024,
K-4024,
K4024,
Melizide,
Mindiab,
Minidiab,
Minodiab,
Ozidia,
glipizide,
29094-61-9,
Glucotrol,
Glydiazinamide,
Melizide,
Glibenese,
Glucozide,
Glupizide,
Sucrazide,
Dipazide,
Glupitel,
Mindiab,
Minidiab,
Minodiab,
Napizide,
Ozidia,
Glucotrol XL,
Glibetin,
Glucolip,
Aldiab,
Digrin,
Glican,
Glidiab,
Glipid,
Minidab,
Glyde,
Gluco-Rite,
Glipizidum,
Glipizida,
Glide,
Metaglip,
Glipizidum [INN-Latin],
Glipizida [INN-Spanish],
CP 28720,
K 4024,
K-4024,
CP-28720,
TK 1320,
C21H27N5O4S,
CP 28,720,
UNII-X7WDT95N5C,
Glipizide (Glucotrol),
EINECS 249-427-6,
MFCD00072159,
BRN 0903495,
CHEMBL1073,
X7WDT95N5C,
1-Cyclohexyl-3-((p-(2-(5-methylpyrazinecarboxamido)ethyl)phenyl)sulfonyl)urea,
MLS000069386,
N-[2-(4-{[(cyclohexylcarbamoyl)amino]sulfonyl}phenyl)ethyl]-5-methylpyrazine-2-carboxamide,
CHEBI:5384,
Glidiazinamide,
Glypidizine,
N-(4-(N-(cyclohexylcarbamoyl)sulfamoyl)phenethyl)-5-methylpyrazine-2-carboxamide,
N-(2-{4-[(cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-5-methylpyrazine-2-carboxamide,
N-(4-(beta-(5-Methylpyrazine-2-carboxamido)ethyl)benzenesulphonyl)-N'-cyclohexylurea,
Pyrazinecarboxamide, N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-5-methyl-,
NCGC00015462-07,
SMR000058455,
CP-28,720,
CAS-29094-61-9,
1-cyclohexyl-3-[[p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl]sulfonyl]urea,
DSSTox_CID_20676,
DSSTox_RID_79535,
Urea, 1-cyclohexyl-3-((p-(2-(5-methylpyrazinecarboxamido)ethyl)phenyl)sulfonyl)-,
DSSTox_GSID_40676,
W-107005,
Semiglynase,
1-cyclohexyl-3-({p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl}sulfonyl)urea,
N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-pyrazine-2-carboxamide,
N-{4-[beta-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulphonyl}-N'-cyclohexylurea,
Glucotrol (TN),
Pyrazinecarboxamide, N-[2-[4-[[[(cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-5-methyl-,
Glipizide [USAN:BAN:INN],
Glipizide (USP/INN),
SR-01000000010,
Glipizibe,
Glipizide, solid,
N-(4-[N-(cyclohexylcarbamoyl)sulfamoyl]phenethyl)-5-methylpyrazine-2-carboxamide,
Glipizide [USAN:USP:INN:BAN],
Glipizide Extended-Release Tablets,
Glipizide,(S),
Prestwick_242,
Glipizide(Glucotrol),
Glipizide, 98+%,
KS-1068,
Metaglip (Salt/Mix),
Lopac-G-117,
Opera_ID_1908,
Prestwick0_000131,
Prestwick1_000131,
Prestwick2_000131,
Prestwick3_000131,
G-117,
AC1L1G0Z,
AC1Q2OG0,
CBiol_001788,
Lopac0_000621,
SCHEMBL17094,
BSPBio_000202,
BSPBio_001349,
KBioGR_000069,
KBioSS_000069,
MLS001148176,
BIDD:GT0476,
SPBio_002141,
BPBio1_000224,
GTPL6821,
DTXSID0040676,
CTK8B3212,
KBio2_000069,
KBio2_002637,
KBio2_005205,
KBio3_000137,
KBio3_000138,
ZJJXGWJIGJFDTL-UHFFFAOYSA-N,
Bio1_000074,
Bio1_000563,
Bio1_001052,
Bio2_000069,
Bio2_000549,
HMS1361D11,
HMS1568K04,
HMS1791D11,
HMS1989D11,
HMS2089C21,
HMS2093J09,
HMS2095K04,
HMS2233N11,
HMS3259K12,
HMS3261N04,
HMS3369L12,
HMS3402D11,
HMS3655G04,
HMS3712K04,
Pharmakon1600-01505433,
ZINC537795,
BCP09195,
HY-B0254,
Tox21_110156,
Tox21_301834,
Tox21_500621,
ANW-41980,
BBL028143,
BDBM50012956,
BG0209,
NSC759120,
s1715,
STK631952,
AKOS005564405,
N-[4-(3-Cyclohexylureidosulfonyl)phenethyl]-5-methyl-2-pyrazinecarboxamide,
Tox21_110156_1,
API0002842,
CCG-204710,
CS-2239,
DB01067,
LP00621,
MCULE-5142805548,
NC00564,
NSC-759120,
IDI1_033819,
N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methylpyrazine-2-carboxamide,
NCGC00015462-01,
NCGC00015462-02,
NCGC00015462-03,
NCGC00015462-04,
NCGC00015462-05,
NCGC00015462-06,
NCGC00015462-08,
NCGC00015462-09,
NCGC00015462-10,
NCGC00015462-11,
NCGC00015462-12,
NCGC00015462-14,
NCGC00016802-01,
NCGC00023748-03,
NCGC00023748-04,
NCGC00023748-05,
NCGC00023748-06,
NCGC00023748-07,
NCGC00255522-01,
NCGC00261306-01,
AC-15789,
AN-15826,
BC209538,
CC-28982,
CPD000058455,
SAM002564210,
SC-13933,
SBI-0050603.P002,
AB0012143,
LS-159679,
TC-063559,
TL8006447,
EU-0100621,
FT-0626714,
FT-0659737,
G0369,
ST50826363,
SW196549-3,
D00335,
094G619,
C-22417,
I06-0186,
I06-1985,
SR-01000000010-2,
SR-01000000010-5,
BRD-K12219985-001-04-8,
BRD-K12219985-001-15-4,
Z1880962274,
Glipizide, European Pharmacopoeia (EP) Reference Standard,
Glipizide, United States Pharmacopeia (USP) Reference Standard,
Glipizide, Pharmaceutical Secondary Standard; Certified Reference Material,
1-cyclohexyl-3-(4-(2-(2-methylpyrazine-5-carboxamido)ethyl)phenylsulfonyl)urea,
N-(4-(.beta.-(5-Methylpyrazine-2-carboxamido)ethyl)benzenesulphonyl)-N'-cyclohexylurea,
N-(2-[4-(([(Cyclohexylamino)carbonyl]amino)sulfonyl)phenyl]ethyl)-5-methyl-2-pyrazinecarboxamide,
N-[2-(4-{[(cyclohexylamino)carbonylamino]sulfonyl}phenyl)ethyl](5-methylpyrazi n-2-yl)carboxamide,
Apamid,
glipizid,
Mixture Name,
Glipizide Kenfarma Brand,
Lacer Brand of Glipizide,
Lilly Brand of Glipizide,
D0Z4SB,
Samarium(III) ionophore I,
Kenfarma Brand of Glipizide,
PfizerBrand 1 of Glipizide,
Glibenese Brand of Glipizide,
Pfizer Brand 2 of Glipizide,
Alphapharm Brand of Glipizide,
Glipizide [USAN:INN:BAN],
CID3478,
Glucotrol XL, Glucotrol, Glipizide,
C21-H27-N5-O4-S,
ZINC00537795,
K4024,
ACN-048274,
CS-O-11661,
A8438,
D005913,
1-Cyclohexyl-3-{4-[2-(5-methylpyrazine-2-carboxamido)ethyl]phenylsulfonyl}urea,
Urea, 1-cyclohexyl-3-[[p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl]sulfonyl]-,
2-Pirazincarboxamida, N-[2-[4-[[[( ciclohexilamino) carbonil] amino] sulfonil] fenil] etil]-5-metil-,
29094-66-4,
N-[2-[4-[[[(Cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-5-methyl-2-pyrazinecarboxamide,
|
| Complexity | 697 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 445.178g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 31 |
| Hydrogen Bond Acceptor Count | 6 |
| Hydrogen Bond Donor Count | 3 |
| Isotope Atom Count | 0 |
| Molecular Weight | 445.538g/mol |
| Monoisotopic Mass | 445.178g/mol |
| Rotatable Bond Count | 7 |
| Topological Polar Surface Area | 139A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 1.9 |
| Symbol: | |
| Hazard statements | |
| Precautionary statements | |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

